Introduction {#s0010}
============

Brown syndrome was first described by Harold Whaley Brown in 1950 as impairment of upward gaze above the horizontal level while the eye is in adduction [@bib0010]. The condition is caused by pathologies involving the superior oblique (SO) tendon-trochlea complex that restricts the passage and movement of SO through the trochlea ([Fig. 1](#f0010){ref-type="fig"}; illustration of the extraocular muscle anatomy). Aside from congenital etiologies, the condition has numerous acquired causes, including trauma, sinus infection, inflammatory diseases e.g. (rheumatoid arthritis and systemic lupus erythematosus), and postoperative complications [@bib0015], [@bib0020], [@bib0025], [@bib0030], [@bib0035], [@bib0040], [@bib0045].Fig. 1Illustration of the extraocular muscle anatomy. Orientation: right eye, axial view, looking down from above.Fig. 1

Computerized tomography (CT) has been used to evaluate SO tendon-trochlea complex abnormalities for Brown syndrome [@bib0050], [@bib0055]. Although CT imaging can be valuable for the diagnosis of Brown syndrome, it has largely been replaced by magnetic resonance imaging (MRI) because of the superior soft tissue resolution offered by the technique [@bib0060], [@bib0065]. For this reason, MRI is superior to CT for most ophthalmologic conditions, especially pathologies that involve extraocular muscles [@bib0070], [@bib0075], [@bib0080], [@bib0085], [@bib0090], [@bib0100].

Here, we describe the MRI features of 2 cases of acquired Brown syndrome, which have not been well reported in the literature.

Case report {#s0015}
===========

Case 1 {#s0020}
------

A 44-year-old female with past medical history of rheumatoid arthritis presented with a 2-week history of left retro-orbital pain and temporal headaches. She also developed transient diplopia with rightward or downward gaze. The left eye remained temporarily disconjugate with these gazes. Upon examination, there seemed to be a physical "catch" with adduction of the left eye. There were no associated visual field deficits, vertigo, facial weakness, or paresthesia.

A review of laboratory values showed positive antinuclear antibody, elevated sedimentation rate, and C-reactive protein levels. Rheumatoid factor was less than 10, and complete blood count, renal function panel, and liver function panel were all within normal limits. The patient\'s long history of rheumatoid arthritis affected her knees and hands bilaterally, but she was not on any immunosuppression medication.

Based on the clinical features, the patient was sent for MRI evaluation. Within the left orbit, there was diffuse asymmetric thickening and enhancement of the left superior oblique muscle, best seen on coronal Short tau inversion recovery (STIR) and postcontrast fat-saturated T1 images ([Fig. 2A, B](#f0015){ref-type="fig"}). The left SO muscle appeared enlarged in the craniocaudal dimension on axial postcontrast fat-saturated T1 images ([Fig. 2C](#f0015){ref-type="fig"}). The enlarged left SO muscle mildly abutted the medial rectus muscle, which otherwise appeared unremarkable. There was also minimal fat stranding within the adjacent left intraconal space.Fig. 2Patient 1. Coronal STIR (A) and postcontrast fat-saturated T1 (B) images; axial postcontrast fat-saturated T1 (C). There is diffuse asymmetric thickening and enhancement of the left superior oblique muscle (arrows). The enlarged left-sided superior oblique muscle mildly abuts the medial rectus muscle, which otherwise is unremarkable (arrow head).Fig. 2

The diagnosis of Brown syndrome was made based on clinical presentation and MRI findings. The patient is to be followed-up in the clinic in a month.

Case 2 {#s0025}
------

A 35-year-old female presented with a 2-year history of diplopia. She complained of wandering left eye since January 2014 and compensated her diplopia with a mild backward head tilt. On examination, she had upward gaze impairment of the left eye, especially on adduction. Optic nerve, macula, and peripheral retina all appeared normal on fundoscopic examination.

Laboratory results were unrevealing as rheumatoid factor, erythrocyte sedimentation rate, complete blood count, renal functional panel, and antinuclear antibody were all normal. The patient had no history of ophthalmologic surgery or other pertinent medical history.

The patient was subsequently sent for imaging. Coronal and axial postcontrast fat-saturated T1 images demonstrated mild asymmetric thickening and enhancement in the expected region of the left SO tendon sheath better than STIR images ([Fig. 3](#f0020){ref-type="fig"}). Specifically, there was prominent enhancement of the SO tendon-trochlea complex on postcontrast fat-saturated T1 images ([Fig. 3](#f0020){ref-type="fig"}). Findings were indicative of a nonspecific inflammatory process of the SO tendon-trochlea complex.Fig. 3Patient 2. Axial STIR (A) and postcontrast fat-saturated T1 (B) images; coronal STIR (C) and postcontrast fat-saturated T1 (D) images. There is subtle increased STIR signal and mild asymmetric thickening in anterior portion of the left superior oblique tendon. On postcontrast imaging, there is prominent enhancement around the trochlea region (B and D, indicated by the arrows).Fig. 3

After the diagnosis of Brown syndrome was made, the patient was treated with a month-long course of 50 mg ibuprofen, 3 times a day. Her diplopia had since improved significantly and no surgical intervention was required.

Discussion {#s0030}
==========

When the condition was first described as "SO tendon sheath syndrome" by Dr. Harold W. Brown in 1950, he postulated that congenitally short anterior SO tendon sheath and inferior oblique palsy were the cause of the condition [@bib0010]. However, anatomic and clinical examinations revealed that the described anterior sheath did not exist, and the condition was inconsistent with inferior oblique palsy [@bib0105]. Further studies showed that the condition was the result of SO tendon-trochlea complex abnormalities that can be attributed to a number of causes [@bib0110], [@bib0115].

Brown syndrome is categorized into congenital (true) and acquired (simulated) types [@bib0040], [@bib0120]. The classification is not only important from an etiology standpoint, but also for treatment and prognosis. Although the exact cause of most congenital cases of Brown\'s syndrome is unknown, abnormalities involving the trochlea or SO tendon that restrict the motion of the SO muscle appears to be the likely culprit [@bib0015], [@bib0050], [@bib0055]. Acquired Brown\'s syndrome includes secondary causes such as trauma, systemic lupus erythematosus, rheumatoid arthritis, sinusitis, periorbital or sinus surgery complications, and myopathies [@bib0060]. Despite reports of systemic disorders being associated with acquired Brown syndrome, most cases are idiopathic. One of our reported patients had a long history of rheumatoid arthritis, which likely contributed to the development of Brown syndrome in her case. The second case presented was probably idiopathic as there were no relevant laboratory findings or significant past medical history. Imaging of the orbit was obtained in both patients as they presented with orbital pain, signs of inflammation, or atypical pattern of strabismus [@bib0050], [@bib0055], [@bib0125].

Imaging is an important part of the workup for Brown syndrome as it helps identify possible mechanisms such as edema, trochlea damage, SO tendon abnormalities, extraocular muscle pulley abnormalities, or congenital abnormalities of the SO tendon-trochlea complex [@bib0115], [@bib0130]. Features of Brown syndrome on CT images include thickening of the SO tendon, local swelling, and enhancement suggestive of inflammatory changes [@bib0135]. Although the combined structures of the trochlea area are discernible, the individual components cannot be differentiated as the trochlea is a cartilaginous structure [@bib0140]. While Brown syndrome has been well characterized on CT imaging, its MRI features are less well described. MRI, in general, is superior to CT for assessing orbital pathologies including those with inflammatory etiologies [@bib0145], [@bib0150]. Fat suppression techniques can further enhance inflammatory and soft tissue features on MRI [@bib0150]. For Brown\'s syndrome, enhancement of the SO tendon-trochlea complex has been the most commonly described feature on MRI [@bib0065].

In our 2 cases of acquired Brown syndrome, abnormalities were clearly visible on MRI. Asymmetric thickening and enhancement of the SO tendon were seen in both patients and better appreciated on coronal postcontrast fat-saturated T1 images than STIR images. Our findings are consistent with the case reported by Currie and Goddard, where they also found thickening of the SO tendon on contrast-enhanced T1 images and hyperintensity on T2-weighted images [@bib0065]. Interestingly, *case 1* demonstrated preferential enhancement of the SO muscle belly, whereas *case 2* exhibited more prominent enhancement of the trochlea region. The relatively diffuse enhancement seen in *case 1* likely reflects a nonspecific inflammatory process, possibly related to the patient\'s systemic disease of rheumatoid arthritis. The specific enhancing feature of the SO tendon-trochlea complex seen in *case 2*\'s MRI is more similar to imaging findings of acquired Brown syndrome reported previously [@bib0065], [@bib0125]. This imaging feature is suggestive of a tendon-trochlea complex abnormality that impairs the passage of SO muscle through the trochlea, leading to local inflammation.

Our report adds to the scarce literature on MRI features of acquired Brown syndrome [@bib0060], [@bib0065]. MRI plays an important role in confirming the diagnosis of Brown syndrome, and radiologists need to be aware of this uncommon and unique condition to make an accurate and timely diagnosis.
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